ACTRN12618001377224: A Phase 1b, Randomized, Blinded, Placebo-Controlled Study to Evaluate the Effect of Selonsertib on Renal Function as Assessed by Markers of Glomerular Filtration Rate in Subjects with Chronic Kidney Disease